Aveta Biomics
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
110 Great Rd Ste 302, Bedford, Massachus...Phone Number
(339) 927-5994Website
www.avetabiomics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Aveta Biomics
Avetabiomics specializes in developing transformative therapies for cancer, focusing on medicines that can effectively treat and prevent cancers without developing resistance. Their platform leverages insights from evolutionary biology to create drugs that address the molecular diversity of tumors, enhancing efficacy and safety. The company utilizes Orthologous Molecular Structures (OMS) to formulate first-in-class drugs that offer durable responses even in the presence of mutating tumors. Avetabiomics aims to serve patients and healthcare providers seeking innovative solutions in cancer treatment.Explore more
Popular SearchesAveta Biomics IncAvetabiomicsSIC Code 28,283NAICS Code 32,325Show moreAveta Biomics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Aveta Biomics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check if Aveta Biomics has recently received funding, and reach out quickly before it becomes old news!
Aveta Biomics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Aveta Biomics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Aveta Biomics recently announced quarterly report
Product Launch: Get notified when Aveta Biomics launches new products
Click to see if Aveta Biomics had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Aveta Biomics has new funding data
Check out if Aveta Biomics is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Aveta Biomics
Compare insights from companies similar to Aveta Biomics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Aveta Biomics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Aveta Biomics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Aveta Biomics.
Aveta Biomics financials insights
Gather financial insights about Aveta Biomics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$41K
Aveta Biomics Tech Stack
A closer look at the technologies used by Aveta Biomics
See more technologies
Aveta Biomics News & Media
Aveta Biomics Announces Podium Presentation of Registrational Phase 3 Head and Neck Cancer Trial at AHNS 2026 Conference
Global Phase 3 study of first oral immunotherapy designed to work independent of PD-L1 across “hot” and “cold” tumors in locally advanced head and neck cancer BEDFORD, MA, UNITED STATES, March 24, 2026 /EINPresswire.com/ -- Aveta Biomics, a clinical …Peter R. Dolan, former Chairman and CEO of Bristol Myers Squibb Joins the Board of Aveta Biomics
Peter Dolan, ex-CEO of Bristol-Myers Squibb, joins Aveta Biomics’ Board to drive breakthrough treatments for Head & Neck Cancer and Glioblastoma. BEDFORD, MA, USA, August 13, 2024 /EINPresswire.com/ -- Aveta Biomics, a pioneering oncology company …Aveta Biomics and CSIR-CDRI Announce License to Aveta Biomics for the Development and Commercialization of First-in-Class Bone Health Drugs
BOSTON and LUCKNOW, India, Feb. 2, 2022 /PRNewswire/ -- CSIR-Central Drug Research Institute (CDRI), Lucknow, one of the premier drug research institutions in the world and Aveta Biomics, USA, a leader in developing the next generation of botanical drugs based on its evolutionary biology...
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Aveta Biomics
Sign Up For FreeTo access detailed company insights
Avetabiomics specializes in developing transformative therapies for cancer, focusing on medicines that can effectively treat and prevent cancers without developing resistance. Their platform leverages insights from evolutionary biology to create drugs that address the molecular diversity of tumors, enhancing efficacy and safety. The company utilize... Read More
